6Atanasijevi-Kunc M, Dfinovec J, Ruigaj S, et al. Simulation a- nalysis of coronary heart disease, congestive heart failure and end -stage renal disease economic burden [ J] . Mathematics and computers in simulation, 2011, 82 (3) : 494 -507.
7De Filippis V, Lancellotti S, Maset F, et al. Oxidation of Met ( 1606 ) in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure[ J ] .The Biochemical Journal, 2012,442 ( 22 ) : 423-432.
8Atanasijevi-Kunc M, Drinovec J, Ruigaj S, et al. Simulation analysis of coronary heart disease, congestive heart failure and end-stage renal disease economic burden[ J ] .Mathematics and computers in simulation, 2011,82 ( 3 ) : 494-507.
9Yingyong Zhao, Xuefeng Shen, Xianlong Cheng, et al. Urinary metabonomics study on the protective effects of ergosta-4,6, 8 ( 14 ),22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF/MS and a novel MS-E data collection technique[ J ]. Process biochemistry,2012,47 ( 12): 1980-1987.
